Works about INSULIN derivatives
Results: 770
Evaluation of the effectiveness of long-acting insulin analogs in patients with type 2 diabetes mellitus.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2023, v. 31, n. 12, p. 2039, doi. 10.1007/s10389-022-01769-1
- By:
- Publication type:
- Article
FDA approves first rapid-acting insulin biosimilar product for treatment of diabetes.
- Published in:
- Rhode Island Medical Journal, 2025, v. 108, n. 3, p. 55
- Publication type:
- Article
Evaluating the Impact of Intensifying Treatment from Human to Analogue Insulin on Glycaemic Control and Insulin Expenditure in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
- Published in:
- Malaysian Journal of Medical Sciences, 2024, v. 31, n. 2, p. 159, doi. 10.21315/mjms2024.31.2.14
- By:
- Publication type:
- Article
Insulin Analogs and Glycosylated Hemoglobin Target of Less Than 7% in Type 2 Diabetes: A Systematic Review of Randomized Trials.
- Published in:
- Metabolic Syndrome & Related Disorders, 2011, v. 9, n. 3, p. 167, doi. 10.1089/met.2010.0134
- By:
- Publication type:
- Article
Long‐Acting Insulin‐Zwitterionic Polymer Conjugate Mitigates Hypoglycemia.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 12, p. 1, doi. 10.1002/chem.202203460
- By:
- Publication type:
- Article
Risk of major cardiovascular events, severe hypoglycaemia, and all-cause mortality for users of insulin degludec versus insulin glargine U100-A Danish cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of time-action profiles of insulin Glargine and NPH insulin in normal and diabetic dogs.
- Published in:
- Veterinary Research Communications, 2008, v. 32, n. 7, p. 563, doi. 10.1007/s11259-008-9059-5
- By:
- Publication type:
- Article
A biotechnological procedure for preparing short peptides and their radioactively labeled analogs for estimating specific binding of Semax and its metabolites in various sections of rat brain.
- Published in:
- Radiochemistry, 2009, v. 51, n. 2, p. 183, doi. 10.1134/S1066362209020167
- By:
- Publication type:
- Article
Prescription analysis of rheumatology and endocrinology departments of a teaching hospital in Western India.
- Published in:
- Journal of Current Research in Scientific Medicine, 2022, v. 8, n. 2, p. 168, doi. 10.4103/jcrsm.jcrsm_26_22
- By:
- Publication type:
- Article
Highlights from the 2021 EASD Annual Meeting. Part 1.
- Published in:
- Diabetes & Primary Care, 2021, v. 23, n. 5, p. 153
- Publication type:
- Article
A locally developed insulin prescribing support aid for type 2 diabetes.
- Published in:
- Diabetes & Primary Care, 2015, v. 17, n. 1, p. 27
- By:
- Publication type:
- Article
Insulin therapy in type 2 diabetes — update.
- Published in:
- Diabetes & Primary Care, 2012, v. 14, n. 3, p. 163
- By:
- Publication type:
- Article
Application of the Neuman's System Model to the Management of Paediatric Case with Gastroenteritis and Type I Diabetes Mellitus.
- Published in:
- Singapore Nursing Journal, 2017, v. 44, n. 2, p. 12
- By:
- Publication type:
- Article
Application of experimental design for determination of insulin analogs.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 75, doi. 10.33320/maced.pharm.bull.2022.68.03.033
- By:
- Publication type:
- Article
Quality study of insulin formulations.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2020, v. 66, p. 151, doi. 10.33320/maced.pharm.bull.2020.66.03.075
- By:
- Publication type:
- Article
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9996193
- By:
- Publication type:
- Article
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9996193
- By:
- Publication type:
- Article
Dual‐hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.
- Published in:
- Artificial Organs, 2021, v. 45, n. 9, p. 968, doi. 10.1111/aor.14023
- By:
- Publication type:
- Article
Phenotypic screening in zebrafish larvae identifies promising cyanobacterial strains and pheophorbide a as insulin mimetics.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-83986-0
- By:
- Publication type:
- Article
Continuous glucose monitoring among adults with type 2 diabetes receiving noninsulin or basal insulin therapy in primary care.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-83548-4
- By:
- Publication type:
- Article
UPLC-MS/MS High-Risk Screening for Sphingolipidoses Using Dried Urine Spots.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 12, p. 1612, doi. 10.3390/biom14121612
- By:
- Publication type:
- Article
Insulin icodec: A novel once‐weekly treatment for diabetes.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 10, p. 1, doi. 10.1111/dme.15414
- By:
- Publication type:
- Article
An exploratory analysis of the cost‐effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 5, p. 1, doi. 10.1111/dme.15303
- By:
- Publication type:
- Article
Real‐world study of the concomitant use of biphasic insulin aspart 30/70 with GLP‐1 receptor agonist versus first‐generation basal insulin with GLP‐1 receptor agonist in type 2 diabetes.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 5, p. 1, doi. 10.1111/dme.15267
- By:
- Publication type:
- Article
Impact of school‐supervised ultra‐long‐acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 10, p. 1, doi. 10.1111/dme.15123
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of once‐daily insulin glargine 300 U/mL versus insulin degludec 100 U/mL using the BRAVO diabetes model.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 9, p. 1, doi. 10.1111/dme.15112
- By:
- Publication type:
- Article
Efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus undergoing coronary artery bypass graft surgery: A non‐inferiority randomized trial.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 1, p. 1, doi. 10.1111/dme.15002
- By:
- Publication type:
- Article
Hyperglycaemia induced by gamma‐butyrolactone.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003–2018.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 8, p. 1, doi. 10.1111/dme.14603
- By:
- Publication type:
- Article
Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID‐19 pandemic.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 7, p. 1214, doi. 10.1111/dme.14328
- By:
- Publication type:
- Article
Are newer insulin analogues better for people with Type 1 diabetes?
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 4, p. 522, doi. 10.1111/dme.13891
- By:
- Publication type:
- Article
A review of the NG17 recommendations for the use of basal insulin in type 1 diabetes.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 2, p. 219, doi. 10.1111/dme.14180
- By:
- Publication type:
- Article
Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre‐trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 2, p. 267, doi. 10.1111/dme.14178
- By:
- Publication type:
- Article
Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 2, p. 256, doi. 10.1111/dme.14094
- By:
- Publication type:
- Article
The importance of prandial insulin bolus timing with hybrid closed‐loop systems.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 12, p. 1716, doi. 10.1111/dme.14116
- By:
- Publication type:
- Article
A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA).
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 1, p. 110, doi. 10.1111/dme.13847
- By:
- Publication type:
- Article
Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification.
- Published in:
- Diabetic Medicine, 2018, v. 35, n. 6, p. 694, doi. 10.1111/dme.13610
- By:
- Publication type:
- Article
Introduction of biosimilar insulins in Europe.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 10, p. 1340, doi. 10.1111/dme.13400
- By:
- Publication type:
- Article
Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial ( BOOST<sup>®</sup> T1).
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 2, p. 167, doi. 10.1111/dme.13068
- By:
- Publication type:
- Article
Insulin degludec/insulin aspart once daily in Type 2 diabetes: a comparison of simple or stepwise titration algorithms ( BOOST<sup>®</sup>: SIMPLE USE).
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 2, p. 174, doi. 10.1111/dme.13069
- By:
- Publication type:
- Article
Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 2, p. 180, doi. 10.1111/dme.13125
- By:
- Publication type:
- Article
Type 1 diabetes: therapeutics and complications.
- Published in:
- Diabetic Medicine, 2013, v. 30, p. 14, doi. 10.1111/dme.12090_9
- Publication type:
- Article
Stepwise intensification of insulin therapy in Type 2 diabetes management-exploring the concept of the basal-plus approach in clinical practice.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 3, p. 276, doi. 10.1111/dme.12019
- By:
- Publication type:
- Article
Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 2, p. 216, doi. 10.1111/dme.12041
- By:
- Publication type:
- Article
Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24-h euglycaemic clamp studies in healthy humans.
- Published in:
- Diabetic Medicine, 2010, v. 27, n. 7, p. 830, doi. 10.1111/j.1464-5491.2010.03026.x
- By:
- Publication type:
- Article
Insulin analogues: Action profiles beyond glycaemic control.
- Published in:
- Archives of Physiology & Biochemistry, 2008, v. 114, n. 1, p. 45, doi. 10.1080/13813450801983369
- By:
- Publication type:
- Article
Water Pipes Corrosion Inhibitors for Q235 Steel in Hydrochloric Acid Medium Using Spiropyrazoles Derivatives.
- Published in:
- Coatings (2079-6412), 2020, v. 10, n. 2, p. 167, doi. 10.3390/coatings10020167
- By:
- Publication type:
- Article
Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association of subclass distribution of insulin antibody with glucose control in insulin-treated type 2 diabetes mellitus: a retrospective observational study.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1141414
- By:
- Publication type:
- Article